
Ask almost any pharmaceutical marketer where the future growth lies for the industry, and the answer will be almost certainly …
Three pharma companies have formed a not-for-profit organisation, the Asian Cancer Research Group (ACRG), to boost work on treating common …
AstraZeneca’s chief executive David Brennan has rejected the strategy of diversification into generics and biosimilars being pursued by many of …
Pfizer is reaching further into emerging markets with the launch of an e-payment scheme that offers patients deep discounts on …
Sanofi-Aventis has partnered with China’s Minsheng Pharmaceuticals to establish a new consumer healthcare joint venture. Sanofi will take a majority …

The global pharma market is expected to grow between 4 to 6% on a constant dollar basis and is expected …

Russia endured a turbulent 2009 in economic terms, thanks to the steep drop in oil prices, but the country is …
Our round-up of developments in the contract research sector includes a fundraising for Ecron Acunova, trial registrations in India a …
Mexico City has announced plans for what it hopes will be a world-class centre for biomedical and nano-medical research.To be …
Pharmaceutical Product Development (PPD) has expanded its capacity to offer drug development services in Asia once again with the acquisition …

China’s allure for pharma companies continues unabated with Merck Serono’s opening of a research and development centre in Beijing. The …

GlaxoSmithKline will increase its reach into emerging markets with a new deal to co-market generics with Dr. Reddy’s.The Indian company …
GlaxoSmithKline has extended its reach into emerging markets by acquiring Bristol-Myers Squibb’s Egyptian mature products business for £125 millionThe move …
Potential lung cancer epidemic looming in AsiaLung cancer is the leading cause of cancer-related mortality throughout much of the industrialized …
Faced with dwindling growth rates in the US and Europe, drug companies are turning their attention towards emerging pharmaceutical markets …